title: Potential withdrawal syndrome associated with SSRI discontinuation.
authors.affiliation: College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Miami 33136, USA.
authors.forename: A L
authors.initials: AL
authors.lastname: Lazowick
authors.forename: G M
authors.initials: GM
authors.lastname: Levin
mesh_terms: D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives; D016666:Fluvoxamine / Q000009:adverse effects*; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline; D013375:Substance Withdrawal Syndrome
chemical_list: D015057:1-Naphthylamine; D016666:Fluvoxamine; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline